FDA Approved: NURTEC ODT — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA supplemental application for Nurtec ODT (rimegepant sulfate) submitted by Pfizer Laboratories Div Pfizer Inc to modify labeling and/or expand indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• NURTEC ODT (RIMEGEPANT SULFATE)

Snippet

SUPPL AP for NURTEC ODT (RIMEGEPANT SULFATE)